AbbVie expands oncology manufacturing facility in Sligo, Ireland

AbbVie announced a $139 million (€113.6 million) expansion of its manufacturing facility in Ballytivnan, Sligo, Ireland, to support its oncology pipeline. The investment will create approximately 100 new jobs over three years.

“The $139 million (€113.6 million) investment in new sterile manufacturing technology at the Ballytivnan site will help deliver promising treatments for cancers with significant unmet medical needs.”gov.ie

• 1 source
• gov.ieAbbVie Expands Oncology Capability at the Company’s Site in Ballytivnan, SligoDepartment of Enterprise, Tourism, EmploymentJan 16, 2018

Summarized from public sources; check the original articles before acting on it.